NHP Financials
This page shows NHP (NHP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Heavy depreciation and interest keep reported losses in place even when core operations briefly turn positive.
The FY2025 operating turnaround from-$123.5M in FY2024 to$3.3M came despite lower revenue, implying FY2024 was driven more by an unusually heavy cost burden than by a lasting sales problem. But cash conversion stayed thin: operating cash flow was only$7.0M while interest expense consumed$61.3M , so the income statement improved faster than the underlying cash engine.
Gross margin stayed in the mid-30s from FY2023 through FY2025, even though operating margin swung from
Cash on hand rebounded to
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of NHP's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
NHP has an operating margin of 1.0%, meaning the company retains $1 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -34.9% the prior year.
NHP's revenue declined 3.3% year-over-year, from $353.8M to $342.3M. This contraction results in a growth score of 32/100.
NHP has a moderate D/E ratio of 1.85. This balance of debt and equity financing earns a leverage score of 64/100.
NHP generates a -9.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -27.8% the prior year.
NHP passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, NHP generates $-0.12 in operating cash flow ($7.0M OCF vs -$57.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
NHP earns $0.1 in operating income for every $1 of interest expense ($3.3M vs $61.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
NHP generated $342.3M in revenue in fiscal year 2025. This represents a decrease of 3.3% from the prior year.
NHP's EBITDA was $81.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 306.6% from the prior year.
NHP reported -$57.7M in net income in fiscal year 2025. This represents an increase of 69.7% from the prior year.
NHP earned $-2.51 per diluted share (EPS) in fiscal year 2025. This represents an increase of 65.1% from the prior year.
Cash & Balance Sheet
NHP held $57.6M in cash against $0 in long-term debt as of fiscal year 2025.
NHP had 28M shares outstanding in fiscal year 2025. This represents an increase of 0.4% from the prior year.
Margins & Returns
NHP's gross margin was 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.4 percentage points from the prior year.
NHP's operating margin was 1.0% in fiscal year 2025, reflecting core business profitability. This is up 35.9 percentage points from the prior year.
NHP's net profit margin was -16.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 36.9 percentage points from the prior year.
NHP's ROE was -9.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 18.2 percentage points from the prior year.
Capital Allocation
NHP Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $84.5M-1.8% | $86.0M+0.8% | $85.3M-1.3% | $86.4M-1.5% | $87.7M-1.4% | $88.9M+0.1% | $88.8M+0.6% | $88.3M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $30.8M-4.3% | $32.2M+2.2% | $31.5M+8.9% | $28.9M-12.0% | $32.8M+1.0% | $32.5M-3.8% | $33.8M+2.0% | $33.2M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $7.9M+39.3% | $5.7M+4.9% | $5.4M+3.7% | $5.2M-5.3% | $5.5M0.0% | $5.5M+17.9% | $4.7M-31.0% | $6.8M |
| Operating Income | -$6.6M-377.1% | $2.4M+143.0% | -$5.5M-142.4% | $13.0M+1334.5% | -$1.1M+95.0% | -$20.9M+79.2% | -$100.4M-8867.9% | -$1.1M |
| Interest Expense | $15.9M+5.3% | $15.1M-4.9% | $15.8M+9.0% | $14.5M-16.0% | $17.3M-3.9% | $18.0M+1.4% | $17.8M+8.4% | $16.4M |
| Income Tax | $101K+53.0% | $66K | $0+100.0% | -$6K-104.7% | $127K | $0-100.0% | $65K-7.1% | $70K |
| Net Income | -$22.8M-81.9% | -$12.5M+39.8% | -$20.8M-1275.2% | -$1.5M+91.1% | -$17.0M+58.2% | -$40.8M+65.1% | -$116.9M-651.9% | -$15.6M |
| EPS (Diluted) | N/A | $-0.56+34.1% | $-0.85-372.2% | $-0.18 | N/A | $-1.56 | $-4.24-532.8% | $-0.67 |
NHP Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.7B-1.6% | $1.7B-1.1% | $1.8B-4.0% | $1.8B-5.9% | $1.9B-2.6% | $2.0B-5.5% | $2.1B-1.0% | $2.1B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $57.6M+22.4% | $47.1M-0.1% | $47.1M-34.0% | $71.4M+229.7% | $21.7M-34.1% | $32.9M+11.5% | $29.5M+2.8% | $28.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $9.3M-9.7% | $10.2M+10.0% | $9.3M+15.0% | $8.1M+38.4% | $5.8M | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.1B+0.1% | $1.1B0.0% | $1.1B-3.9% | $1.2B-8.3% | $1.3B-2.6% | $1.3B-4.5% | $1.4B+8.1% | $1.2B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $600.1M-4.3% | $627.2M-3.1% | $647.0M-4.1% | $674.6M-1.5% | $684.6M-2.6% | $702.6M-7.1% | $756.7M-13.8% | $877.7M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NHP Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.0M-2.1% | $10.2M+26.3% | $8.1M+137.9% | -$21.2M-428.9% | $6.5M+106.8% | -$95.2M-1589.9% | $6.4M+151.4% | $2.5M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$3.3M-10.8% | -$3.0M-58.3% | -$1.9M-102.4% | $78.0M+1342.8% | $5.4M-92.7% | $74.1M+2305.3% | -$3.4M+72.5% | -$12.2M |
| Financing Cash Flow | -$712K+90.9% | -$7.8M+73.5% | -$29.4M-553.0% | -$4.5M+80.2% | -$22.7M-190.6% | $25.0M+1537.2% | $1.5M+129.2% | -$5.2M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NHP Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.5%-0.9pp | 37.4%+0.5pp | 36.9%+3.5pp | 33.4%-4.0pp | 37.4%+0.9pp | 36.6%-1.5pp | 38.1%+0.5pp | 37.5% |
| Operating Margin | -7.8%-10.5pp | 2.8%+9.2pp | -6.5%-21.5pp | 15.1%+16.3pp | -1.2%+22.3pp | -23.5%+89.6pp | -113.1%-111.8pp | -1.3% |
| Net Margin | -27.0%-12.4pp | -14.6%+9.8pp | -24.4%-22.7pp | -1.8%+17.7pp | -19.4%+26.4pp | -45.8%+85.8pp | -131.6%-114.0pp | -17.6% |
| Return on Equity | -3.8%-1.8pp | -2.0%+1.2pp | -3.2%-3.0pp | -0.2%+2.3pp | -2.5%+3.3pp | -5.8%+9.7pp | -15.4%-13.7pp | -1.8% |
| Return on Assets | -1.3%-0.6pp | -0.7%+0.5pp | -1.2%-1.1pp | -0.1%+0.8pp | -0.9%+1.2pp | -2.0%+3.5pp | -5.5%-4.8pp | -0.7% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 1.85+0.1 | 1.76+0.1 | 1.710.0 | 1.71-0.1 | 1.830.0 | 1.83+0.1 | 1.78+0.4 | 1.42 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
What is NHP's annual revenue?
NHP (NHP) reported $342.3M in total revenue for fiscal year 2025. This represents a -3.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is NHP's revenue growing?
NHP (NHP) revenue declined by 3.3% year-over-year, from $353.8M to $342.3M in fiscal year 2025.
Is NHP profitable?
No, NHP (NHP) reported a net income of -$57.7M in fiscal year 2025, with a net profit margin of -16.9%.
What is NHP's EBITDA?
NHP (NHP) had EBITDA of $81.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is NHP's gross margin?
NHP (NHP) had a gross margin of 36.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is NHP's operating margin?
NHP (NHP) had an operating margin of 1.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is NHP's net profit margin?
NHP (NHP) had a net profit margin of -16.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is NHP's return on equity (ROE)?
NHP (NHP) has a return on equity of -9.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is NHP's operating cash flow?
NHP (NHP) generated $7.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are NHP's total assets?
NHP (NHP) had $1.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What is NHP's debt-to-equity ratio?
NHP (NHP) had a debt-to-equity ratio of 1.85 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is NHP's return on assets (ROA)?
NHP (NHP) had a return on assets of -3.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is NHP's Piotroski F-Score?
NHP (NHP) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are NHP's earnings high quality?
NHP (NHP) has an earnings quality ratio of -0.12x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can NHP cover its interest payments?
NHP (NHP) has an interest coverage ratio of 0.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is NHP?
NHP (NHP) scores 16 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.